A detailed history of Susquehanna Fundamental Investments, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 22,096 shares of ADPT stock, worth $78,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,096
Holding current value
$78,219
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$2.88 - $4.8 $63,636 - $106,060
22,096 New
22,096 $70.9 Million
Q3 2023

Nov 14, 2023

SELL
$5.07 - $8.44 $233,676 - $388,999
-46,090 Reduced 51.51%
43,389 $236,000
Q2 2023

Aug 11, 2023

SELL
$6.19 - $8.78 $80,234 - $113,806
-12,962 Reduced 12.65%
89,479 $600,000
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $641,280 - $956,798
102,441 New
102,441 $782,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $506M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.